Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Cash from Investing Activities came in at -$4.1 million in Q1 2026, up 6.74% year-on-year from -$3.8 million in Q1 2025, and down 32.9% on a QoQ basis from -$3.1 million in Q4 2025.
Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cash from Investing Activities data on file, last reported at -$4.1 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 6.74% year-over-year to -$4.1 million in Q1 2026; TTM through Mar 2026 was -$12.9 million, a 20.82% decrease from a year earlier, with the FY2025 full-year figure at -$13.2 million, down 87.09% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$4.1 million, down from -$3.1 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for JUSHF reached as high as $1.7 million in Q2 2024 and fell as low as -$38.1 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$6.6 million across 5 years, with a median of -$4.1 million in 2026.
- On a YoY basis, Cash from Investing Activities climbed as much as 348.1% in 2024 and fell as far as 2112.2% in 2024.
- Year by year, Cash from Investing Activities stood at -$7.7 million in 2022, then jumped by 95.76% to -$328000.0 in 2023, then plunged by 2112.2% to -$7.3 million in 2024, then surged by 57.69% to -$3.1 million in 2025, then tumbled by 32.9% to -$4.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$4.1 million in Q1 2026, -$3.1 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | -4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.08 Mn |
| Mar 31, 2026 | -4.08 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | -5.32 Mn |
| Sep 30, 2025 | -5.32 Mn |
| Jun 30, 2025 | -459,000.00 |
| Jun 30, 2025 | -459,000.00 |
| Mar 31, 2025 | -4.38 Mn |
| Mar 31, 2025 | -4.38 Mn |
| Dec 31, 2024 | -7.26 Mn |
| Dec 31, 2024 | -7.26 Mn |
| Sep 30, 2024 | -770,000.00 |
| Sep 30, 2024 | -770,000.00 |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | -743,000.00 |
| Mar 31, 2024 | -743,000.00 |
| Dec 31, 2023 | -328,000.00 |
| Dec 31, 2023 | -328,000.00 |